Home Page  / Our Company  / Newsroom
International R&D Collaboration Summit and Fair

Hasbiotech İlaç San. ve Tic. A.Ş participates in International R&D Collaboration Summit and Fair as a Support Sponsor which is held in Pullman Fair and Congress Center between May 3-5, 2017 in order to establish institutional and interpersonal scientific and commercial cooperation grounds integrated with the development objectives of the country and increase national and international awareness of the services and activities including the public, university and private sectors.

4th National Hospital and Institutional Pharmacists Congress

The 4th National Hospital and Institutional Pharmacists Congress, which you will find opportunities to evaluate the developing and renewing aspects of the pharmacy profession in the light of scientific and up-to-date information, to examine professional problems and to propose solutions to the authorized institutions and to contribute to professional development, will take place at Hilton Dalaman between 8-12 March 2017.

Hasbiotech, a member of IEIS and Biotechnological Pharmaceutical Platform...

Our company is a member of IEIS (Pharmaceutical Manufacturers Association of Turkey), which was founded in 1964 and which focuses on improving working conditions in pharmaceutical industry, making contributions to the development of health policies, and realizing many other fundamental objectives as such, at the same time contributing to the industry in general, as of January 3, 2017. Having acquired the vision of marketing the domestic molecule to be discovered in Turkey by Turkish specialists throughout the world, our company wishes to express its appreciation for being given the opportunity to contribute to the activities of IEIS.

Our President grants Award to Hasbiotech…

Our President Recep Tayyip Erdogan participated in the ceremony organised by Kayseri Chamber of Industry on December 4, 2016 in order to grant awards to well-established companies that contribute to export, employment and development by means of their investments, and said the following:

World-wide quality award to Hasbiotech opening to the world from Kayseri…

Thanks to its contribution to “Leadership”, “Quality”, “Innovation” and “Excellency” principles, the Turkish firm Hasbiotech has been granted “2016 International Quality Award” which is accepted as the most prestigious quality award in the world. Having received the award in Frankfurt within a ceremony attended by international leaders, Hasbiotech has been a source of pride for our country.

Cuba’s Biotechnology Revolution

Opening its doors to the world in April 2016, Cuba continues to achieve revolutionary developments in the treatment of many diseases with dozens of vaccines, including cancer drugs that it developed with its powerful biotechnology industry despite limited opportunities.

Hasbiotech attends CPhIİstanbul fair.

Organized for the 3rd time in 2016, the CPhIİstanbul Pharmaceutical Exhibition will be held between June 1 and 3 at the Istanbul Congress Center, Harbiye. As Hasbiotech İlaç San. ve Tic. A.Ş., we will be present at our stand no: B151. We will be delighted to gather with you at our stand throughout the event.

Hasbiotech attended the 4th International Meeting on Pharmacy and Pharmaceutical Sciences

The 4th International Meeting on Pharmacy and Pharmaceutical Sciences sponsored by Hasbiotech together with others was held between September 18 and 21 at the Haydarpaşa Campus of the Marmara University. Our General Manager Dr. Seyfullah Dağıstanlı along with other speakers attended the congress, where Princess of Thailand Chulabhorn, a Professor of Pharmacology, made a presentation.

The Cuban Revolution in Kayseri

Transferring technology from Cuba, Hasbiotech İlaç will develop the first Hepatitis C vaccine in Kayseri. In the plant whose foundation will be laid in February, the vaccine developed against Hepatitis C whose treatment costs 18 billion dollars annually all over the world will be sold for 100 dollars.

The Thrill of First Ever Domestic Molecule in Pharmaceutics

Turkey is counting the days to manufacture its first ever pharmaceutical molecule. Has Group of Kayseri and Dr. Dağıstanlı will be investing in a molecule to treat Hepatitis C. Dr. Dağıstanlı said “We are very close to the end”.

Hasbiotech Logo

Original files in JPG, PNG and Vector PDF file formats of our logo are available here.

Information in our website will not replace information provided by a physician or pharmacist. Hasbiotech does not assume any legal responsibility for cases arising out of the abuse or misuse of information and references contained hereunder. The information offered in this website is intended for target users and may not be distributed to third parties or copied by others. Unauthorized use of registered marks and texts in this website is not allowed. By using this website, all users are deemed to have accepted this legal warning.

You may access the remaining part of the website only after confirming that you are a healthcare professional (physician, pharmacist, dentist etc.).

Click the “I agree” button if you are confirming that you are a healthcare professional (physician, pharmacist, dentist etc.). Otherwise, click the “I do not agree” button.
I agree I do not agree